Irish AI-based health platform Cambrean has been acquired by US health technology company Nucleus for an undisclosed sum. As part of the deal, Cambrean founder David Sloane will join NUcleus, and ...

According to Grand View Research, the European and Middle Eastern drug screening markets are projected to grow significantly by 2030, with Europe expected to reach $3.6 billion and the Middle East and ...